Seikagaku (TSE:4548) Research & Development : 円7,694 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Seikagaku Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Seikagaku's Research & Development for the three months ended in Dec. 2023 was 円1,688 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was 円7,694 Mil.

Seikagaku Research & Development Historical Data

The historical data trend for Seikagaku's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seikagaku Research & Development Chart

Seikagaku Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Research & Development

Get a 7-Day Free Trial

7,148.00

6,877.00

7,209.00

9,005.00

7,951.00

Seikagaku Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Research & Development	Get a 7-Day Free Trial															1,948.00	2,596.00	1,738.00	1,672.00	1,688.00

Seikagaku Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7,694 Mil.

Seikagaku (TSE:4548) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Seikagaku Research & Development Related Terms

Thank you for viewing the detailed overview of Seikagaku's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Seikagaku (TSE:4548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Seikagaku Corp (TSE:4548) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005

Website

http://www.seikagaku.co.jp

Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.

Seikagaku (TSE:4548) Headlines

No Headlines